SKN | Obesity Biotech Kailera Therapeutics Sets Terms for $500 Million IPO
Kailera Therapeutics, a clinical-stage biotechnology company focused on obesity and metabolic disorders, has set terms for a $500 million IPO as it prepares for...
SKN | TTM Technologies Earnings Preview: Can TTMI Sustain Its Breakout Rally?
TTM Technologies, Inc. (NASDAQ: TTMI) has recently captured investor attention following a sharp upward move in its stock price, climbing to around $121 after...
SKN | Blackstone-Backed Encore Files for Estimated $500 Million IPO in Event Services Sector
Encore, an event services provider backed by Blackstone, has filed for an estimated $500 million IPO as it prepares to re-enter the public markets....
SKN | CarMax Earnings Preview: Can KMX Overcome Declining Sales and Stage a Comeback?
Earnings Day Approaches Amid Uncertainty
CarMax, Inc. (NYSE: KMX) is set to report earnings on April 14, 2026, with investors closely watching for signs of...
SKN | Can Kandi Technologies Deliver a Turnaround as EV Hype Fades?
Key Points
Kandi Technologies Group stock remains weak, trading under $1 and significantly underperforming despite operating in the EV sector.
Persistent losses and poor...